| Product Information |
|
| Registration Number |
BR-1401
|
| Generic Name |
Trastuzumab
|
| Brand Name |
Kanjinti
|
| Dosage Strength |
150 mg
|
| Dosage Form |
Powder For Concentrate For Solution For Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
20 mL Type I borosilicate glass vial with a butyl rubber stopper and an aluminum seal with flip-off dust cover (box of 1's)
|
| Manufacturer |
Amgen Technology (Ireland) Unlimited Company
|
| Country of Origin |
Ireland
|
| Trader |
N/A
|
| Importer |
Zuellig Pharma Corporation
|
| Distributor |
Zuellig Pharma Corporation
|
| Application Type |
Initial
|
| Issuance Date |
20 May 2022
|
| Expiry Date |
20 May 2027
|